Abstract
Considering the importance of hydantoin derivatives in treatment of status epilepticus, four 5-phenylhydantoins, whose lipophilicities were estimated to be similar to that of phenytoin, were synthesized. Evaluation of their anticonvulsant activities was performed on rats by subcutaneous pentylenetetrazol seizure test and intravenous pentylenetetrazol threshold test, and spontaneous locomotor activity test was used to assess possible sedative effects. X-ray analysis of three compounds suggested that certain analogies might be drawn between interactions in crystal packing and biological interactions responsible for their anticonvulsant activity. It was found that 5-ethyl-5-phenyl-3-propylhydantoin exhibits the most favorable pharmacological properties among the synthesized compounds, i.e., anticonvulsant activity comparable to phenytoin with lower liability for induction of sedation in rats.
Graphical Abstract
Similar content being viewed by others
References
Yaari Y, Selzer ME, Pincus JH (1986) Ann Neurol 20:171
Danielsson BR, Skold AC, Azarbayjani F (2001) Curr Pharm Des 7:787
Willow M, Kuenzel EA, Catterall WA (1984) Mol Pharmacol 25:228
Willow M, Gonoi T, Catterall WA (1985) Mol Pharmacol 27:549
Troupin AS, Friel P, Lovely MP, Wilensky AJ (1979) Ann Neurol 6:410
Smythies JR (1980) Receptor modeling for anticonvulsant and convulsant drugs. In: Glaser GH, Penry JK, Kiffin J, Woodbury DM (eds) Advances in neurology, vol 27. Raven, New York, p 207
Trišović N, Valentić N, Erović M, Đaković–Sekulić T, Ušćumlić G, Juranić I (2011) Monatsh Chem 142:1227
Scholl S, Koch A, Henning D, Kempter G, Kleinpeter E (1999) Struct Chem 10:355
Zha C, Brown GB, Brouillette WJ (2004) J Med Chem 47:6519
Camerman A, Camerman N (1971) Acta Crystallogr B27:2205
Brouillette WJ, Brown GB, DeLorey TM, Liang G (1990) J Pharm Sci 79:871
Brown ML, Brown GB, Brouillette WJ (1997) J Med Chem 40:602
Sechi G, Rosati G, Deiana GA, Petruzzi V, Deriu F, Correddu P, De Riu PL (1997) Brain Res 764:230
Trinka E (2009) Epilepsia 50:40
Lamberty Y, Klitgaard H (2000) Epilepsy Behav 1:256
Dimmock JR, Puthucode RN, Smith JM, Hetherington M, Quail JW, Pugazhenthi U, Lechler T, Stables JP (1996) J Med Chem 39:3984
Jones GP, Andrews PR (1987) J Chem Soc Perkin Trans 2 4:415–421
Bucherer HT, Lieb VA (1934) J Prakt Chem 141:5
Suzuki H, Kneller MB, Rock DA, Jones JP, Trager WF, Rettie AE (2004) Arch Biochem Biophys 429:1
Trišović N, Valentić N, Ušćumlić G (2011) Chem Cent J 5:62
Fabrique de produits chimiques ci-devant Sandoz (1934) Therapeutic compounds. FR Patent 769,667, Aug 31, 1934; (1934) Chem Abstr 29:12252
Kocer HB, Worley SD, Broughton RM, Acevedo O, Huang TS (2010) Ind Eng Chem Res 49:11188
Altomare A, Cascarano G, Giacovazzo C, Guagliardi A, Burla MC, Polidori G, Camalli M (1994) J Appl Cryst 27:435
Sheldrick GM (2008) Acta Crystallogr A64:112
Farrugia LJ (1999) J Appl Crystallogr 32:837
Mandhane SN, Aavula K, Rajamannar T (2007) Seizure 16:636
Savić MM, Milinković MM, Rallapalli S, Clayton ST, Joksimović S, Van Linn M, Cook JM (2009) Int J Neuropsychopharmacol 12:1179
Acknowledgments
This work was performed within the framework of research project no. 172013 supported by the Ministry of Education and Science of the Republic of Serbia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trišović, N., Timić, T., Divljaković, J. et al. Synthesis, structural and biological characterization of 5-phenylhydantoin derivatives as potential anticonvulsant agents. Monatsh Chem 143, 1451–1457 (2012). https://doi.org/10.1007/s00706-012-0791-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-012-0791-8